vs

Side-by-side financial comparison of Danaher Corporation (DHR) and Sempra (SRE). Click either name above to swap in a different company.

Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $3.3B, roughly 1.8× Sempra). Danaher Corporation runs the higher net margin — 17.3% vs 10.7%, a 6.6% gap on every dollar of revenue. On growth, Sempra posted the faster year-over-year revenue change (6.9% vs 3.7%). Danaher Corporation produced more free cash flow last quarter ($1.1B vs $-2.2B). Over the past eight quarters, Danaher Corporation's revenue compounded faster (1.8% CAGR vs -5.8%).

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

Sempra is a North American public utility holding company based in San Diego, California. The company is one of the largest utility holding companies in the United States with nearly 40 million consumers.

DHR vs SRE — Head-to-Head

Bigger by revenue
DHR
DHR
1.8× larger
DHR
$6.0B
$3.3B
SRE
Growing faster (revenue YoY)
SRE
SRE
+3.3% gap
SRE
6.9%
3.7%
DHR
Higher net margin
DHR
DHR
6.6% more per $
DHR
17.3%
10.7%
SRE
More free cash flow
DHR
DHR
$3.3B more FCF
DHR
$1.1B
$-2.2B
SRE
Faster 2-yr revenue CAGR
DHR
DHR
Annualised
DHR
1.8%
-5.8%
SRE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DHR
DHR
SRE
SRE
Revenue
$6.0B
$3.3B
Net Profit
$1.0B
$352.0M
Gross Margin
60.3%
Operating Margin
22.6%
7.2%
Net Margin
17.3%
10.7%
Revenue YoY
3.7%
6.9%
Net Profit YoY
7.9%
-47.9%
EPS (diluted)
$1.45
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHR
DHR
SRE
SRE
Q1 26
$6.0B
Q4 25
$6.8B
$3.3B
Q3 25
$6.1B
$2.8B
Q2 25
$5.9B
$2.7B
Q1 25
$5.7B
$3.7B
Q4 24
$6.5B
$3.1B
Q3 24
$5.8B
$2.6B
Q2 24
$5.7B
$2.5B
Net Profit
DHR
DHR
SRE
SRE
Q1 26
$1.0B
Q4 25
$1.2B
$352.0M
Q3 25
$908.0M
$95.0M
Q2 25
$555.0M
$473.0M
Q1 25
$954.0M
$917.0M
Q4 24
$1.1B
$676.0M
Q3 24
$818.0M
$649.0M
Q2 24
$907.0M
$725.0M
Gross Margin
DHR
DHR
SRE
SRE
Q1 26
60.3%
Q4 25
58.0%
Q3 25
58.2%
Q2 25
59.3%
Q1 25
61.2%
Q4 24
59.5%
Q3 24
58.7%
Q2 24
59.7%
Operating Margin
DHR
DHR
SRE
SRE
Q1 26
22.6%
Q4 25
22.0%
7.2%
Q3 25
19.1%
10.6%
Q2 25
12.8%
17.3%
Q1 25
22.2%
21.5%
Q4 24
21.8%
35.0%
Q3 24
16.5%
12.9%
Q2 24
20.3%
18.8%
Net Margin
DHR
DHR
SRE
SRE
Q1 26
17.3%
Q4 25
17.5%
10.7%
Q3 25
15.0%
3.4%
Q2 25
9.3%
17.5%
Q1 25
16.6%
24.9%
Q4 24
16.6%
22.0%
Q3 24
14.1%
25.3%
Q2 24
15.8%
29.2%
EPS (diluted)
DHR
DHR
SRE
SRE
Q1 26
$1.45
Q4 25
$1.69
$0.53
Q3 25
$1.27
$0.12
Q2 25
$0.77
$0.71
Q1 25
$1.32
$1.39
Q4 24
$1.50
$1.04
Q3 24
$1.12
$1.00
Q2 24
$1.22
$1.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHR
DHR
SRE
SRE
Cash + ST InvestmentsLiquidity on hand
$29.0M
Total DebtLower is stronger
$29.0B
Stockholders' EquityBook value
$31.6B
Total Assets
$110.9B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHR
DHR
SRE
SRE
Q1 26
Q4 25
$29.0M
Q3 25
$5.0M
Q2 25
$155.0M
Q1 25
$1.7B
Q4 24
$1.6B
Q3 24
$560.0M
Q2 24
$228.0M
Total Debt
DHR
DHR
SRE
SRE
Q1 26
Q4 25
$18.4B
$29.0B
Q3 25
$16.9B
$29.0B
Q2 25
$17.4B
$34.9B
Q1 25
$16.5B
$33.3B
Q4 24
$16.0B
$31.6B
Q3 24
$17.5B
$31.0B
Q2 24
$17.0B
$29.0B
Stockholders' Equity
DHR
DHR
SRE
SRE
Q1 26
Q4 25
$52.5B
$31.6B
Q3 25
$51.1B
$31.2B
Q2 25
$52.3B
$31.7B
Q1 25
$50.8B
$31.6B
Q4 24
$49.5B
$31.2B
Q3 24
$51.3B
$29.7B
Q2 24
$49.9B
$29.5B
Total Assets
DHR
DHR
SRE
SRE
Q1 26
Q4 25
$83.5B
$110.9B
Q3 25
$79.9B
$106.9B
Q2 25
$81.6B
$99.9B
Q1 25
$79.1B
$99.0B
Q4 24
$77.5B
$96.2B
Q3 24
$80.6B
$93.7B
Q2 24
$78.6B
$90.5B
Debt / Equity
DHR
DHR
SRE
SRE
Q1 26
Q4 25
0.35×
0.92×
Q3 25
0.33×
0.93×
Q2 25
0.33×
1.10×
Q1 25
0.32×
1.05×
Q4 24
0.32×
1.01×
Q3 24
0.34×
1.04×
Q2 24
0.34×
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHR
DHR
SRE
SRE
Operating Cash FlowLast quarter
$1.3B
$1.2B
Free Cash FlowOCF − Capex
$1.1B
$-2.2B
FCF MarginFCF / Revenue
18.2%
-67.7%
Capex IntensityCapex / Revenue
4.0%
104.0%
Cash ConversionOCF / Net Profit
1.28×
3.38×
TTM Free Cash FlowTrailing 4 quarters
$5.3B
$-6.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHR
DHR
SRE
SRE
Q1 26
$1.3B
Q4 25
$2.1B
$1.2B
Q3 25
$1.7B
$1.1B
Q2 25
$1.3B
$784.0M
Q1 25
$1.3B
$1.5B
Q4 24
$2.0B
$1.4B
Q3 24
$1.5B
$1.0B
Q2 24
$1.4B
$669.0M
Free Cash Flow
DHR
DHR
SRE
SRE
Q1 26
$1.1B
Q4 25
$1.7B
$-2.2B
Q3 25
$1.4B
$-1.5B
Q2 25
$1.1B
$-1.5B
Q1 25
$1.1B
$-854.0M
Q4 24
$1.5B
$-1.1B
Q3 24
$1.2B
$-913.0M
Q2 24
$1.1B
$-1.2B
FCF Margin
DHR
DHR
SRE
SRE
Q1 26
18.2%
Q4 25
25.5%
-67.7%
Q3 25
22.6%
-52.6%
Q2 25
18.4%
-56.3%
Q1 25
18.4%
-23.2%
Q4 24
23.0%
-35.4%
Q3 24
21.0%
-35.5%
Q2 24
19.7%
-49.4%
Capex Intensity
DHR
DHR
SRE
SRE
Q1 26
4.0%
Q4 25
5.4%
104.0%
Q3 25
4.8%
92.9%
Q2 25
4.2%
85.3%
Q1 25
4.3%
63.5%
Q4 24
7.9%
79.9%
Q3 24
5.1%
75.3%
Q2 24
5.0%
76.4%
Cash Conversion
DHR
DHR
SRE
SRE
Q1 26
1.28×
Q4 25
1.77×
3.38×
Q3 25
1.83×
11.68×
Q2 25
2.41×
1.66×
Q1 25
1.36×
1.62×
Q4 24
1.86×
2.02×
Q3 24
1.85×
1.57×
Q2 24
1.56×
0.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons